Taking on the Challenges of Creating New Value by Offering Superior Products and Accurate Information

We believe BORRAGINOL® represents as the symbol of Amato’s “founding spirit” and it will soon mark the 100th anniversary of its creation. Amato’s founding spirit is “placing life and health of patients first and foremost,” and “putting both ‘product quality’ and ‘information quality’ into practice”. Amato’s mission is to give people who are suffering from pain and discomfort “Peace of Mind, and Sense of Excitement.”

Although 100 long years have passed and many of our predecessors and employees have been involved, Amato maintains its founding spirit unchanged. We would like to express our gratitude to our many stakeholders who have made it possible for us to retain Amato’s founding spirit, including medical professionals, scientists, government officials, distributors, and all of whom have provided their criticisms and their warm support. We also appreciate our employees and shareholders for their contributions. Most of all, we would like to show our appreciation to patients for their daily use of Amato products. Their feelings of satisfaction have been the wellspring of our efforts.

As we mark the 100th anniversary of Amato’s founding this year, we have recently made the decision to become a member of the ROHTO Group as a subsidiary of ROHTO Pharmaceutical Co., Ltd.

Nevertheless, we would like to take this opportunity to renew our heartfelt pledge to everyone including patients and for those desiring good health that we will continue to contribute with our heart and soul to their well-being.

With “NEVER SAY NEVER” as its corporate identity, ROHTO declares that it will never give up, will change the impossible into the possible, and will continue to challenge beyond the boundaries of common sense.

As a member of the ROHTO Group, we will continue to work in close collaboration and cooperation, and always remain true to the spirit of our founding and take on the challenge of creating even greater value in the next 100 years.

September 2021

Amato Pharmaceutical Products, Ltd.
Takashi Miyazaki
President, Representative Director, Chief Executive Officer